Results 31 to 40 of about 63,958 (182)
A Clinical Comparative Study of Piperacillin and Sulbactam/Ampicillin in Patients with Community-Acquired Bacterial Pneumonia [PDF]
Objective To evaluate the clinical usefulness of piperacillin (4 g/day) therapy for community-acquired pneumonia compared to sulbactam/ampicillin (6 g/day).
Higashiyama, Yasuhito +10 more
core +1 more source
Treating childhood pneumonia in hard-to-reach areas: a model-based comparison of mobile clinics and community-based care. [PDF]
BACKGROUND: Where hard-to-access populations (such as those living in insecure areas) lack access to basic health services, relief agencies, donors, and ministries of health face a dilemma in selecting the most effective intervention strategy. This paper
Francesco Checchi +8 more
core +1 more source
Application of hsa-miR-10a-5p in severe community acquired pneumonia [PDF]
Objective To explore the role of hsa-miR-10a-5p in severe community acquired pneumonia (SCAP) and to evaluate the potential of hsa-miR-10a-5p as a SCAP biomarker.
YE Jun, LIU Dan-yu, HE Quan, HUANG Feng-ming, ZHU Hua-dong, XU Jun, JIANG Cheng-yu
doaj
Severe Community-Acquired Pneumonia [PDF]
Community-acquired pneumonia refers to an infection of the lung parenchyma acquired outside a healthcare setting. The term severe CAP (SCAP) signifies a more serious form of community-acquired pneumonia that requires admission to the intensive care unit and has a high risk of mortality.
Puneet Saxena +3 more
openaire +2 more sources
Vitamin D, innate immunity and outcomes in community acquired pneumonia
We investigated the associations between vitamin D status, the antimicrobial peptides cathelicidin and beta defensin-2 and outcomes in community acquired pneumonia.
Karalus, Noel +9 more
core +1 more source
SEVERE COMMUNITY-ACQUIRED PNEUMONIA
Community-acquired pneumonia (CAP) is likely to be severe in the very elderly, and clinically significant in those with hepatic/ renal insufficiency, cardiopulmonary disease, or, impaired host defenses. Pathogens in mild, moderately severe, and severe CAP are the same. These pathogens determine prognosis, complications, and duration of therapy. Empiric
openaire +2 more sources
The identification and management of adults presenting with pneumonia is a major challenge for primary care health professionals. This paper summarises the key recommendations of the British Thoracic Society (BTS) Guidelines for the management of ...
Woodhead, Mark A +10 more
core +1 more source
BACKGROUND: Emerging epidemiological evidence suggests that statins may reduce the risk of community-acquired pneumonia (CAP) and its complications. PURPOSE: Performed a systematic review to address the role of statins in the prevention or treatment ...
Imad M Tleyjeh +39 more
core +2 more sources
Etiology of severe community - acquired pneumonia in adults: results of the first Russian multicenter study [PDF]
Aim: to study the etiology of severe community - acquired pneumonia (SCAP) in adults in Russian Federation. SCAP is distinguished by high mortality and socio - economic burden.
I A Zakharenkov +11 more
doaj +1 more source
Severe community acquired pneumonia [PDF]
Research into community acquired pneumonia over the past two decades has focused on developing tools to measure the severity of illness and which antibiotics to choose. Several tools can now help clinicians identify patients with severe community acquired pneumonia in clinical settings.1 In people with severe disease, international guidelines recommend
Graham D Mills, Richard Laing
openaire +1 more source

